Home

Amit Munshi

CIK 1612551 · President and CEO · last filed 2026-06-22

Amit Munshi is a President and CEO who has filed 59 SEC Form 4 insider transactions across 8 companies since 2014. The most recent filing, for ZURA, was dated Jun 22, 2026. Across all open-market trades the lifetime net is −$27.3M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $5.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.52M

Companies

8

Total Filings

59

Lifetime Open-Market Net

-$27.27M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ZURA Director 777,384 $5.54 $4.31M $0 4 2026-06-22
ARQT Director 9,799 $28.42 $278.5K $0 2 2026-06-09
IKT Director 403,176 $2.31 $931.3K $500.1K 5 2026-02-24
Damora Therapeutics, Inc. (GLTO) Delisted Director 192 $28.69 $5.5K $0 5 2025-06-20
Zura Bio Ltd (ZURAW) Delisted Director 777,384 $1.08 $839.6K $1000.0K 3 2024-04-24
ARENA PHARMACEUTICALS INC (ARNA) Delisted President and CEO 114,647 $99.99 $11.46M -$28.99M 24 2022-03-11
PULM Director — $1.68 — $0 6 2021-02-01
EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted Chief Executive Officer 301,841 — — $221.8K 10 2016-03-01

Recent Filings

59 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-22 ZURA Grant (A) — $0 EDGAR
2026-06-09 ARQT Grant (A) +5,778 $0 EDGAR
2026-02-24 IKT Disp (D) −19,089 $0 EDGAR
2025-12-08 ARQT Grant (A) +2,021 $0 EDGAR
2025-08-28 IKT Grant (A) +57,265 $0 EDGAR
2025-07-02 IKT Grant (A) — $0 EDGAR
2025-06-20 Damora Therapeutics, Inc. (GLTO) Delisted Grant (A) — $0 EDGAR
2025-05-22 ZURA Grant (A) — $0 EDGAR
2025-02-19 IKT Grant (A) — $0 EDGAR
2024-12-11 ZURA Grant (A) — $0 EDGAR
Showing 1–10 of 59
Page 1 of 6
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.